Advertisement

Topics

RTI Surgical® Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth

08:00 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Restructuring Underway and Overall Business Beginning to Stabilize RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the fourth quarter and full year of 2016. Th...

Other Sources for this Article

RTI Surgical
Robert Jordheim
Interim Chief Executive Officer
rjordheim@rtix.com
or
Roxane Wergin, 386-418-8888
Director, Corporate Communications
rwergin@rtix.com

NEXT ARTICLE

More From BioPortfolio on "RTI Surgical® Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...